Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This is a 3-week study to evaluate FEV1 following treatment with drugs in persistent asthma
which is also active during allergy seasons in pediatric patients with seasonal aeroallergen
sensitivity.